News

Monogram Orthopaedics Inc., a company specializing in medical technology for reconstructive joint procedures and surgical robotics, has successfully delivered its inaugural surgical robot to one of the largest global distributors of robotics.

“Delivering our first robot and realizing our first commercial revenues validates our technology and represents a pivotal milestone for our strategic roadmap,” said Ben Sexson, Chief Executive Officer of Monogram Orthopaedics. “Our system is performing at an extremely high level. We now look forward to seeing how our robot competes and scales in the real world. We hope to see the mBôs robot contribute to advancing the standard of care for orthopedic patients worldwide.”

Monogram’s mission is to enhance the standard of care in orthopedic joint replacement surgery through advanced, next-generation active surgical robotics. Currently, about 88% of knee replacement surgeries, which represent the company’s primary market, are conducted manually. The mBôs robot seeks to integrate safety, user-friendliness, cost efficiency, innovative implant design, extensive clinical functionality, and speed, aiming to propel the next phase of robotic adoption in orthopedics.


© Monogram Orthopaedics Inc